000 | 01458 a2200397 4500 | ||
---|---|---|---|
005 | 20250515043826.0 | ||
264 | 0 | _c20061208 | |
008 | 200612s 0 0 eng d | ||
022 | _a1533-4880 | ||
024 | 7 |
_a10.1166/jnn.2006.440 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTiwari, Sandip B | |
245 | 0 | 0 |
_aImproved oral delivery of paclitaxel following administration in nanoemulsion formulations. _h[electronic resource] |
260 |
_bJournal of nanoscience and nanotechnology _c |
||
300 |
_a3215-21 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xadministration & dosage |
650 | 0 | 4 |
_aDrug Carriers _xchemistry |
650 | 0 | 4 |
_aDrug Compounding _xmethods |
650 | 0 | 4 | _aEmulsions |
650 | 0 | 4 |
_aExcipients _xchemistry |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aMetabolic Clearance Rate |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aNanostructures _xchemistry |
650 | 0 | 4 | _aOrgan Specificity |
650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
650 | 0 | 4 | _aParticle Size |
650 | 0 | 4 | _aTissue Distribution |
700 | 1 | _aAmiji, Mansoor M | |
773 | 0 |
_tJournal of nanoscience and nanotechnology _gvol. 6 _gno. 9-10 _gp. 3215-21 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1166/jnn.2006.440 _zAvailable from publisher's website |
999 |
_c16624102 _d16624102 |